anti-VEGF療法

Latest news

Tag

Evaluating Anti-VEGF Retreatment Outcomes in Diabetic Macular Edema Patients Returning After Lost to Follow-Up with Stabilized Vision

This nationwide study examines visual and anatomical responses to anti-VEGF retreatment in diabetic macular edema patients who returned with stabilized vision after being lost to follow-up, highlighting suboptimal gains and implications for

Oct 23, 2026

Diabetes & Endocrinology

Real-World Eligibility of Diabetic Macular Edema Patients for Anti-VEGF Trials: Implications for Clinical Practice and Health Equity

A significant proportion of real-world diabetic macular edema patients are excluded from clinical trials of anti-VEGF therapy due to stringent systemic criteria, disproportionately affecting racial minorities. This study highlights the need

Sep 10, 2026

news

FAc Intravitreal Implant Achieves Comparable Visual Outcomes with 53% Fewer Injections in Diabetic Macular Edema: Phase 4 NEW DAY Study

The Phase 4 NEW DAY study demonstrates that fluocinolone acetonide (FAc) 0.19 mg implant as baseline therapy achieves similar visual acuity and anatomical improvements compared to aflibercept in diabetic macular edema patients, while signif

Apr 2, 2026